Cite
HARVARD Citation
Eliasson, J. et al. (2022). Apraglutide, a novel glucagon‐like peptide‐2 analog, improves fluid absorption in patients with short bowel syndrome intestinal failure: Findings from a placebo‐controlled, randomized phase 2 trial. JPEN, Journal of parenteral and enteral nutrition. 46 (4), pp. 896-904. [Online].